In this study, we found that some CD8 T cells expressed high levels of immune checkpoint genes in tumor or metastatic lymph node, such as PD-1, PD-L1 and CTLA4, suggesting that ICIs can be effective for CC treatment. This evidence concerns the gene PDCD1 and neoplasm.